Clinical Trial Update: DOAC in Chinese Patients With Atrial Fibrillation

View source ↗

Summary

An ongoing clinical trial evaluating direct oral anticoagulants in Chinese patients with atrial fibrillation to prevent stroke and other thromboembolic events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Atrial Fibrillation, Stroke | Status: RECRUITING